Home › Employers › Invahealth Inc.
Invahealth Inc.: H-1B salaries and sponsorship
Invahealth Inc. filed 14 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 14. Median offered salary: $67,500.
Does Invahealth Inc. sponsor H-1B visas?
Invahealth Inc. filed 14 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 9, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Director, R & D and Regulatory Compliance | 1 | $130,000 |
| Quality Assurance and Compliance Specialist | 1 | $59,197 |
| Quality Control Senior Chemist | 1 | $60,902 |
| Production and Packaging Supervisor | 1 | $59,197 |
| Analytical Laboratory Supervisor | 1 | $70,000 |
| Regulatory Complaince Associate | 1 | $60,549 |
| Quality Control Specialist | 1 | $63,086 |
| Pharmaceutical Analytical Chemist (method & Compliance) | 1 | $85,000 |
| Quality Control Validation Chemist | 1 | $80,974 |
| Pharmaceutical Product and Packaging Development Specialist | 1 | $80,974 |
| Quality Specialist | 1 | $65,000 |
| Senior Manager, Quality Assurance | 1 | $141,190 |
| Senior Manager Quality Control Assurance | 1 | $100,000 |
| Compliance and Regulatory Specialist - Chemist | 1 | $64,230 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 5 | $60,902 |
| FY2025 | 8 | $80,974 |
| FY2026 | 1 | $64,230 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
- Chemists8
- Regulatory Affairs Specialists3
- Industrial Production Managers1
- Medical and Clinical Laboratory Technologists1
- Regulatory Affairs Managers1
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Compliance and Regulatory Specialist - Chemist | $64,230 Level I | Cranbury, NJ | Jun 9, 2026 | Oct 1, 2026 | Certified |
| Quality Control Validation Chemist | $80,974 Level II | Cranbury, NJ | Aug 21, 2025 | Aug 28, 2025 | Certified |
| Pharmaceutical Product and Packaging Development Specialist | $80,974 Level II | Cranbury, NJ | Aug 13, 2025 | Aug 20, 2025 | Certified |
| Quality Specialist | $65,000 Level I | Cranbury, NJ | Jul 21, 2025 | Sep 30, 2025 | Certified |
| Senior Manager, Quality Assurance | $141,190 Level II | Cranbury, NJ | Jul 14, 2025 | Jul 21, 2025 | Certified |
| Senior Manager Quality Control Assurance | $100,000 Level III | Cranbury, NJ | Jul 2, 2025 | Jul 9, 2025 | Certified |
| Pharmaceutical Analytical Chemist (method & Compliance) | $85,000 Level II | Cranbury, NJ | May 28, 2025 | Jun 4, 2025 | Certified |
| Quality Control Specialist | $63,086 Level I | Cranbury, NJ | Oct 15, 2024 | Oct 22, 2024 | Certified |
| Regulatory Complaince Associate | $60,549 Level I | Cranbury, NJ | Oct 15, 2024 | Oct 22, 2024 | Certified |
| Analytical Laboratory Supervisor | $70,000 Level II | Cranbury, NJ | Aug 1, 2024 | Sep 30, 2024 | Certified |
| Quality Control Senior Chemist | $60,902 Level I | Cranbury, NJ | Jun 13, 2024 | Oct 1, 2024 | Certified |
| Production and Packaging Supervisor | $59,197 Level I | Cranbury, NJ | Jun 13, 2024 | Oct 1, 2024 | Certified |
| Quality Assurance and Compliance Specialist | $59,197 Level I | Cranbury, NJ | Jun 13, 2024 | Oct 1, 2024 | Certified |
| Director, R & D and Regulatory Compliance | $130,000 Level II | Cranbury, NJ | Feb 6, 2024 | Mar 21, 2024 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).